Notice of AGM
02/03/2026 07:00
RNS Number : 7282U
Malin Corporation PLC
02 March 2026
Malin Corporation plc
Notice of 2026 AGM
Dublin-Ireland, 2 March 2026: Malin Corporation plc (Euronext Growth Dublin:MLC) ("Malin", the "Company"), a company investing in highly innovative life sciences companies, today confirms that its 2026 Annual General Meeting ("AGM") will be held in the Conrad Dublin Hotel, Earlsfort Terrace, Dublin 2, D02 V562, Ireland at 10:00 a.m. GMT on Thursday, 26 March 2026.
The Letter from the Chair, Notice of Annual General Meeting and Form of Proxy have been issued to shareholders. Copies of all documents relating to the AGM (including the Company's 2025 Annual Report) are also available on the Company's website at www.malinplc.com.
The Notice of AGM sets out the resolutions to be proposed at the AGM and the processes by which shareholders may vote in connection with the AGM.
ENDS
About Malin Corporation plc
Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com.
For further information contact:
Malin
Fiona Dunlevy, CEO/ Company Secretary
Tel: +353 (0)1 905 3531
cosec@malinplc.com
Andrea Stafford, Head of Finance
Tel: +353 (0)1 905 3531
astafford@malinplc.com
Davy Corporate Finance (Euronext Growth Listing Sponsor & Broker)
Brian Garrahy / Daragh O'Reilly
Tel: +353 1 679 6363
Sodali & Co (Media enquiries)
Eavan Gannon
Tel: +353 87 236 5973
eavan.gannon@sodali.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOAZZGZZLNDGVZG